Related Experiment Video
Updated: May 14, 2026
04:46
Changing the Direction and Orientation of Electric Field During Electric Pulses Application Improves Plasmid Gene Transfer in vitro
Published on: September 12, 2011
An approach towards bronchoscopic-based gene therapy using electrical field accelerated plasmid droplets.
D Hradetzky1, S Boehringer, Th Geiser
1University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, Institute for Medical and Analytical Technologies, 4132 Muttenz, Switzerland. david.hradetzky@fhnw.ch
Summary
Gene therapy offers new hope for idiopathic pulmonary fibrosis (IPF) by restoring lung self-healing. A novel device delivers therapeutic genes to the distal lung epithelium, overcoming cellular barriers for potential IPF treatment.
Area of Science:
- Pulmonary Medicine
- Biotechnology
- Medical Devices
Background:
- Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by impaired alveolar epithelial repair.
- Current therapeutic options for IPF are limited, necessitating novel treatment strategies.
- Gene therapy holds promise for restoring lung self-healing mechanisms in IPF.
Purpose of the Study:
- To develop a novel therapeutic instrument for gene delivery to the distal lung epithelium.
- To investigate the feasibility of using an electrical field for gene transduction in lung tissue.
- To create a device compatible with minimally invasive procedures like bronchoscopy.
Main Methods:
- Concept development and experimental validation of an electrical field-based gene delivery device.
- Utilizing charged plasmid droplets accelerated towards lung tissue.
- Assessing the device's ability to overcome cell membranes via impact energy.
Main Results:
- Demonstrated the concept of an electrical field-driven gene delivery system.
- Presented initial experimental data supporting the device's functionality.
- Showcased the potential for gene transduction in the distal lung epithelium.
Conclusions:
- The developed device shows potential for effective gene delivery to the distal lung.
- This technology could enable gene therapy for IPF by targeting alveolar epithelial cells.
- Integration into bronchoscopy offers a minimally invasive approach for future IPF treatments.
